The current valuation score of Ionis Pharmaceuticals Inc is 7.20, ranking 258 out of 368 in the Biotechnology & Medical Research industry. Its current P/E ratio is -28.77, which is -70.25% below the recent high of -8.56 and -87.00% above the recent low of -53.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.